| Log IL-10 (pg/ml) |
|
|
|
|
| Intent-to-treat analysis | ||||
| Time | −0.12 | 0.04 | −2.87 | 0.005 |
| Main effect of group | 0.11 | 0.16 | 0.66 | 0.514 |
| Group × time interaction | 0.13 | 0.06 | 2.11 | 0.037 |
| Per-protocol analysis | ||||
| Time | −0.11 | 0.05 | −2.33 | 0.021 |
| Main effect of group | 0.09 | 0.19 | 0.47 | 0.642 |
| Group × time interaction | 0.12 | 0.06 | 1.93 | 0.056 |
| STRESS HORMONES | ||||
| Log Cortisol (mg/L creatinine) | ||||
| Intent-to-treat analysis | ||||
| Time | −0.03 | 0.02 | −1.34 | 0.181 |
| Main effect of group | 0.08 | 0.07 | 1.18 | 0.241 |
| Group × time interaction | −0.04 | 0.03 | −1.17 | 0.245 |
| Per-protocol analysis | ||||
| Time | −0.01 | 0.03 | −0.53 | 0.598 |
| Main effect of group | 0.11 | 0.08 | 1.36 | 0.175 |
| Group × time interaction | −0.05 | 0.04 | −1.38 | 0.170 |
| Log Epinephrine (mg/L creatinine) |
| |||
| Intent-to-treat analysis | ||||
| Time | −0.24 | 0.05 | −4.86 | <0.0001 |
| Main effect of group | −0.19 | 0.13 | −1.43 | 0.156 |
| Group × time interaction | 0.13 | 0.07 | 1.88 | 0.063 |
| Per-protocol analysis | ||||
| Time | −0.25 | 0.05 | −4.51 | <0.0001 |
| Main effect of group | −0.15 | 0.15 | −0.98 | 0.328 |
| Group × time interaction | 0.11 | 0.08 | 1.52 | 0.130 |
| Log Norepinephrine (mg/L creatinine) |
| |||
| Intent-to-treat analysis | ||||
| Time | −0.04 | 0.03 | −1.29 | 0.200 |
| Main effect of group | −0.06 | 0.08 | −0.76 | 0.447 |
| Group × time interaction | 0.05 | 0.04 | 1.15 | 0.253 |
| Per-protocol analysis | ||||
| Time | −0.04 | 0.03 | −1.34 | 0.184 |
| Main effect of group | −0.07 | 0.09 | −0.78 | 0.438 |
| Group × time interaction | 0.05 | 0.04 | 1.04 | 0.301 |